PEY16 COST-UTILITY ANALYSIS FOR PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION IN THE UK- THE IMPACT OF DEMOGRAPHIC AND DISEASE CHARACTERISTICS
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63722-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63722-9/fulltext
Title :
PEY16 COST-UTILITY ANALYSIS FOR PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION IN THE UK- THE IMPACT OF DEMOGRAPHIC AND DISEASE CHARACTERISTICS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63722-9&doi=10.1016/S1098-3015(10)63722-9
First page :
Section Title :
Open access? :
No
Section Order :
574